S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

PURE Bioscience Short Interest Ratio and Short Volume

+0.04 (+13.54 %)
(As of 10/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume33,817 shs
Average Volume43,749 shs
Market Capitalization$29.26 million
P/E RatioN/A
Dividend YieldN/A

PURE Bioscience (OTCMKTS:PURE) Short Interest Data

Current Short Volume3,800 shares
Previous Short Volume29,100 shares
Change Vs. Previous Month-86.94%
Dollar Volume Sold Short$1,487.70
Short Interest Ratio / Days to Cover0.1
Last Record DateSeptember, 30 2021
Outstanding Shares87,223,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume33,817 shares
Average Trading Volume43,749 shares
Today's Volume Vs. Average-22.70%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling PURE Bioscience ?

Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter.

PURE Bioscience (OTCMKTS:PURE) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/20213,800 shares $1,487.70 -86.9%N/A0.1 $0.39
9/15/202129,100 shares $12,236.55 +419.6%N/A0.2 $0.42
8/31/20215,600 shares $2,024.68 -11.1%N/A0 $0.36
8/13/20216,300 shares $2,387.07 +152.0%N/A0.2 $0.38
7/30/20212,500 shares $1,050.00 No ChangeN/A0.1 $0.42
7/15/20212,500 shares $1,102.75 -30.6%N/A0.1 $0.44
6/30/20213,600 shares $1,638.00 +28.6%N/A0 $0.46
6/15/20212,800 shares $1,343.44 -6.7%N/A0.1 $0.48
5/28/20213,000 shares $1,530.00 +25.0%N/A0 $0.51
5/14/20212,400 shares $1,488.00 No ChangeN/A0 $0.62
4/30/20212,400 shares $1,488.00 +50.0%N/A0.1 $0.62
4/15/20211,600 shares $1,120.00 No ChangeN/A0 $0.70
3/31/20211,600 shares $1,160.00 -63.6%N/A0 $0.73
3/15/20214,400 shares $3,124.00 +7.3%N/A0 $0.71
2/26/20214,100 shares $3,198.00 -46.8%N/A0.1 $0.78
2/12/20217,700 shares $6,006.00 +57.1%N/A0.1 $0.78
1/29/20214,900 shares $3,724.00 -71.8%N/A0.1 $0.76
1/15/202111,600 shares $9,628.00 -4.1%N/A0.1 $0.83
12/31/202023,500 shares $21,150.00 +102.6%N/A0.1 $0.90
12/15/202011,600 shares $10,556.00 -4.1%N/A0.1 $0.91
11/30/202012,100 shares $12,826.00 +26.0%N/A0.2 $1.06
11/15/20209,600 shares $12,480.00 +5.5%N/A0.1 $1.30
10/30/20209,100 shares $12,103.00 -15.0%N/A0.2 $1.33
10/15/202010,700 shares $14,980.00 -60.8%N/A0.1 $1.40
9/30/202027,300 shares $46,655.70 +58.7%N/A0.3 $1.71

PURE Bioscience (OTCMKTS:PURE) Short Interest FAQ

PURE Bioscience (OTCMKTS:PURE) Short Interest Frequently Asked Questions

What is PURE Bioscience's current short interest?

Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 3,800 shares of PURE short. Learn More on PURE Bioscience's current short interest.

Is PURE Bioscience's short interest increasing or decreasing?

PURE Bioscience saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 3,800 shares, a decline of 86.9% from the previous total of 29,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does PURE Bioscience's short interest compare to its competitors?

0.00% of PURE Bioscience's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to PURE Bioscience: Orgenesis Inc. (1.91%), NervGen Pharma Corp. (0.00%), Cyclerion Therapeutics, Inc. (0.00%), Odonate Therapeutics, Inc. (2.01%), Hepion Pharmaceuticals, Inc. (2.27%), Second Sight Medical Products, Inc. (0.00%), Freeline Therapeutics Holdings plc (0.23%), Genprex, Inc. (0.00%), Applied Genetic Technologies Co. (8.52%), and Skylight Health Group Inc. (0.47%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short PURE Bioscience stock?

Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. PURE Bioscience's stock is trading up $0.04 today. To short PURE Bioscience stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that PURE Bioscience will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against PURE Bioscience?

A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further.

How often is PURE Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is September, 30 2021.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.